USA-UK Angels Network
Investing in UK entrepreneurs - next meeting date April 24th
Companies run in the UK or in the USA by UK educated entrepreneurs
The group consists of accredited investors who are interested in investing in UK companies or US companies that have UK linkages such as entrepreneurs who are British or are have been educated in the UK. Typically companies are technology oriented to match the interests of the group.
Next meeting April 24th at 8am Pacific Time / 4pm UK time.
To get a Zoom invite click the buttons below.
About
Our Principles
Organized from London and San Francisco, the group meets a few times a year to evaluate and invest in British linked companies either online or in-person. The group welcomes invitations from other angel groups both in the US and the UK, either to attend each others meetings or for syndicated deals.
Contact:
Co-Founder and Director
Anastasiya Giarletta, anastasiya@r42group.com
Investment Positions
We lead and invest early
We lead, and invest early and are active in helping companies using the networks of our angel investors.
Algodynamix
Financial Risk Forecasting
Algodynamix provides warnings, days or hours in advance of major market directional movements. RJN provided the earliest funds and advice.
Lexicus
SOLD TO MOTOROLA
Cursive handwriting recognition
This project came out of students at Stanford, and was co-founded by RJN. Became successful and sold to Motorola and drove early speech and handwriting recognition, text prediction and smart phones out of Motorola in both western and chinese markets.
Cellmania
SOLD TO RIM/BLACKBERRY
The first mobile app store
Cellmania built the first mobile app stores in 1999, and made a name for itself driving billions of downloads. Co-founded by RJN, was successfully sold to BlackBerry in 2010.
VocalIQ
SOLD TO APPLE
Speech recognition dialogue
VocalIQ develops natural language processing systems to amend speech recognition systems. Based in Cambridge, UK, RJN took an advisory board position. Company was sold to Apple in 2016.
Kaptivo, SOLD TO LIFESIZE
Smart whiteboard sharing
Based in Cambridge, UK, the team of around a dozen PhD image processing experts were making a unique product that allowed a camera to go in front of a regular whiteboard. RJN invested into the company at a key time, provided working capital debt financing and helped get VCs to follow on.
8Power
Low power sensors using energy harvesting
8Power came out of Cambridge University, developing technology to harvest energy from vibrations and allowing IOT sensors to last decades without battery replacement. RJN invested at a key time, with new management being installed.
CloudCath
Detects complications in peritoneal dialysis
Team came out of Stanford and targets the peritoneal dialysis market which allows people to do dialysis at home. Cloudcath solves the problem of detecting complications instantly rather than waiting several days. This allows peritoneal dialysis to be done at home instead of spending all day at the clinic. RJN is an early investor.
Transparent Choice
Software platform for making decisions
Transparent Choice provides a platform for enterprises to make decisions as a group more accurately. RJN is a very early investor and has supported the team as it has grown.
Exonate
Solving macular degeneration with eye drops
By exploiting the alternative splicing of vascular endothelial growth factor (VEGF) Exonate aims to use cutting-edge technology to introduce an eye drop to treat wet AMD and DME. RJN invested early as some of the first funds.
Virtual Arts
Virtual and Augmented Reality Solutions
Virtual Arts uses its proprietary engine to built efficient and fast solutions. Amongst the first investors in Virtual Arts, RJN helped the company with strategy and positioning in the emerging industry of Virtual and Augmented reality.
Oxford Drug Design
Designing new antibiotics
Oxford Drug Design has developed rapid, state-of-the-art virtual screening and ligand analogue searching technologies to help with the drug discovery process. Utilising this technology platform the company has developed novel antibiotic programs. RJN invested early into the company.
Unbound
Make publishing work. For everybody.
Unbound believes that everyone should be given the chance to seize their own success. Unbound has created a community, platform and a publishing model that shift the balance of power to the people and communities that champion underserved ideas and voices.
Tripism
Business Travel Platform Rebuilt
Tripism has rebuilt business travel from the ground up to bring a smarter, faster way to plan and book your next trip. RJN provided fund very early and has supported the company throughout, taking a seat on the board.
Novopangea Technologies
Converting non-food biomass into liquid fuels and a range of useful chemicals.
Nova Pangaea Technologies (NPT) has developed a staged, progressive, physical and thermochemical process – Refnova – which enables a complete fractionation of lignocellulosic materials into their constituent parts. Covered by patents in the USA and many other countries, the NPT process takes green feedstock as cut and uses no bioactives such as enzymes or bacteria. Internally catalysed it is continuous (“tubular”), fast (minutes), simple and clean. RJN invested early into the venture.
Contact
Do you have an idea you think we need to know about? Get in touch with us.
